Asia Pacific Insulin Syringes Market Report to 2027 - Size, Share & Industry Trends Analysis - ResearchAndMarkets.com

2022-07-16 00:15:05 By : Mr. lidong chen

DUBLIN, May 20, 2022--(BUSINESS WIRE)--The "Asia Pacific Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific Insulin Syringes Market is expected to witness market growth of 6.1% CAGR during the forecast period (2021-2027).

Insulin syringes are widely used among diabetic patients for easier diabetes care, with around 40% of patients injecting insulin using these syringes. Insulin syringes are single-use disposable devices. This ensures that the needles are sterile, reducing the danger of infection from previously used needles. To minimize lipohypertrophy, or an abnormal fat accumulation under the skin, it's also necessary to rotate injection sites. With daily insulin shots, it's a frequent problem. Insulin is injected subcutaneously - that is, just under the skin - to avoid the needle puncturing muscle, which might alter the blood sugar levels.

As the prevalence of diabetes rises, so will the need for insulin, which will have a favourable impact on market growth. Patients are increasingly using portable tools like insulin syringes for more convenient diabetes care, with roughly 40.0 percent of diabetics injecting insulin with syringes.

In China, unhealthy diets and a lack of physical activity are contributing to rising rates of overweight and obesity, both of which are risk factors for Type 2 diabetes. In China, more than a third of adults are overweight, with 7% of persons being obese. Youngsters in China are also at danger of acquiring diabetes as a result of unhealthy lifestyles: more than 4 in 5 teenagers aged 11 to 17 do not receive adequate physical activity, and obesity in children are fast rising. As a result, increased diabetes cases will propel the Insulin Syringes Market forward.

The China market dominated the Asia Pacific Insulin Syringes Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $182 million by 2027. The Japan market is anticipated to grow a CAGR of 5.6% during (2021 - 2027). Additionally, The India market is expected to showcase a CAGR of 6.8% during (2021 - 2027).

Market Segments Covered in the Report:

Hindustan Syringes & Medical Devices Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/rq9ftj

View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005150/en/

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

(Reuters) -The judge overseeing Twitter Inc's $44 billion lawsuit against Elon Musk has a no-nonsense reputation as well as the distinction of being one of the few jurists who has ever ordered a reluctant buyer to close a U.S. corporate merger. Kathaleen McCormick took over the role of chancellor or chief judge of the Court of Chancery last year, the first woman in that role. On Wednesday, she was assigned the Twitter lawsuit which seeks to force Musk to complete his deal for the social media platform, which promises to be one of the biggest legal showdowns in years.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is joining its tech peers in a stock split. The trillion-dollar tech giant, which is the parent company of Google, plans to do a 20:1 stock split on Friday, July 15. If you're aiming to buy Alphabet before the stock split, the clock is ticking.

Rogers knows how to survive — and thrive — in turbulent times.

The market is unstable. Your portfolio doesn’t need to be.

Intel ( ) is the bearer of additional bad news. The chip giant will give an extra blow to consumers and businesses concerned about the health of the economy. For several weeks in fact, consumers have seen their bills for groceries and other products increase.

The deal talks are still on track but coming data and arbitration slowed the timeline, people familiar with the matter say.

To the oil industry, there is no single price of oil. Instead, there are multiple like Brent, Dubai, and WTI, each for a particular grade of crude. Russia has its own grade of oil—and its price is languishing.

Yahoo Finance Live checks out several of the day's trending stocks, including UnitedHealth Group's profit beat and gaming stocks popping off after an influx of Tiger Woods sports bets.

Specifically, Germany is reportedly moving to legalize adult-use marijuana by 2024 following a sea change in its political leadership. Second, there were rumblings out of Washington, D.C., that a long-awaited Senate bill to legalize marijuana was close to a vote. As this German push to legalize cannabis for adult use is still two years away, and the aforementioned Senate bill doesn't appear to have the votes needed to pass, speculators are apparently rethinking their positions.

Shares of some of the world's biggest technology companies gained ground on Friday after several difficult sessions for the market. Semiconductor specialist Nvidia (NASDAQ: NVDA) was up as much as 2.4%, social media giant Meta Platforms (NASDAQ: META) rose as much as 3.7%, and customer relationship management (CRM) specialist Salesforce (NYSE: CRM) climbed as much as 3.8%. The catalyst that sent a wide swath of technology stocks higher today was a read on consumer spending, which was more robust than many had predicted.

(Bloomberg) -- Carson Block was on a Delta flight to New York when he felt blood pooling on his seat.Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesBiden to Leave Mideast With No Immediate Announcement on OilTrump Allies Line Up Shadow Government, Mindful of 2016’s ChaosIt’s a tale the famous, filter-free founder of trading firm Muddy Waters Capital launches into to make a point about misdoings among short

Goldman Sachs slashed its earnings forecast for chipmakers and semiconductors due to fears of a slowdown in global growth.

Russia is positioning itself to engage in 'expropriation blackmail,' according to Mark Dixon, founder of the Moral Rating Agency.

The head of the company now running the former McDonald's Corp chain of restaurants in Russia told RBC TV that producers of French fries are refusing to supply to the country and warned that attempts to increase domestic processing are fraught with difficulties. McDonald's quit Russia after a Western backlash against Moscow's military campaign in Ukraine, which included a barrage of economic sanctions, and sold all the restaurants it owned to a local licensee in May. CEO Oleg Paroev told Reuters the chain had sold almost 120,000 burgers on opening day.

Mining stocks could capitulate given waning demand for industrial metals

Every investor wants to see his stocks pay off – or he wouldn’t be in the markets. But finding the right investment, the ‘one’ that will bring profits, can sometimes be challenging, especially in today's market conditions. The two simplest courses of action an investor can take to ensure solid returns are based on common sense. The first is to buy low and sell high. That is, find a cheap stock with sound fundamentals and good prospects for growth – and buy in to take advantage of the growth pote

Bill Gates has promised to give "virtually all" of his fortune away. Where will it go?

Most retired workers depend on multiple streams of income during their retirement. Two of the most common such income streams are Social Security and pensions. If we look at pension vs. Social Security income, we find significant differences. Retired workers … Continue reading → The post Pension vs. Social Security: Key Differences appeared first on SmartAsset Blog.

(Bloomberg) -- Former Treasury Secretary Lawrence Summers issued one of his harshest criticisms yet of the Federal Reserve’s slowness in moving to raise interest rates, and warned that policy makers are still presenting forecasts that are unrealistic.Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesBiden to Leave Mideast With No Immediate Announcement on OilTrump Allies Line Up Shadow Government, Mindful of

Home sale cancellations soared in June. But why?